Adrian Rawcliffe

Board Member

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

ADAPY

Current role

Board Member, CEO

WVE

Current role

Board Member

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2021	Adaptimmune Therapeutics PLC (ADAPY)	Chief Executive Officer	$617,050	—	—	$3,207,291	$351,719	$38,941	$4,215,001
2020	Adaptimmune Therapeutics PLC (ADAPY)	Chief Executive Officer	$574,000	—	—	$1,715,346	$378,840	$33,416	$2,701,602
2019	Adaptimmune Therapeutics PLC (ADAPY)	Chief Executive Officer	$500,481	—	—	$1,427,399	$177,251	$49,912	$2,155,042

No earnings-call appearances or filed executive changes recorded yet.